Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$331K Sell
6,920
-2,770
-29% -$134K 0.04% 216
2019
Q3
$483K Sell
9,690
-1,475
-13% -$75.3K 0.07% 165
2019
Q2
$597K Sell
11,165
-1,026
-8% -$53.6K 0.08% 141
2019
Q1
$643K Sell
12,191
-20
-0.2% -$1.04K 0.09% 129
2018
Q4
$574K Sell
12,211
-1,870
-13% -$97.5K 0.09% 124
2018
Q3
$812K Sell
14,081
-130
-0.9% -$7.2K 0.11% 101
2018
Q2
$773K Sell
14,211
-635
-4% -$31.5K 0.11% 107
2018
Q1
$702K Buy
+14,846
New +$744K 0.1% 117

Other funds holding NTR

CIBC Bank USA's NTR Position: Q4 2019 in Review

CIBC Bank USA reduced its Nutrien (NTR) stake by 29% in Q4 2019, selling an estimated $134K and leaving 6,920 shares worth $331K. The position accounts for 0.04% of the portfolio, ranked #216.

CIBC Bank USA first reported a position in NTR in Q1 2018 and has held it in 8 quarters since. The position peaked at $812K in Q3 2018. 549 funds tracked by Wall St. Rank hold NTR as of Q4 2019.

  • CIBC Bank USA held 6,920 shares of Nutrien worth $331K as of Q4 2019.
  • CIBC Bank USA sold 2,770 Nutrien shares in Q4 2019, an estimated $134K.
  • Nutrien made up 0.04% of CIBC Bank USA's portfolio in Q4 2019, its #216 holding.
  • CIBC Bank USA first reported a position in Nutrien in Q1 2018 and has held it in 8 quarters since.
  • CIBC Bank USA's Nutrien position peaked at $812K in Q3 2018.
  • 549 funds tracked by Wall St. Rank held Nutrien as of Q4 2019.

Based on CIBC Bank USA's 13F filing for Q4 2019, filed 29 Jan 2020.